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ORIGINAL RESEARCH • MUSCULOSKELETAL IMAGING
S
oft-tissue masses are common and a frequent reason for 
performing musculoskeletal imaging. he primary aim 
of imaging in this setting is to obtain a provisional or de-
initive diagnosis of any underlying lesion. Where a mass 
is identiied but characterization is not possible, the over-
arching question referring physicians have is whether the 
mass could be malignant (1). Despite the ubiquity of soft-
tissue lesions, the majority are benign, with lipomas the 
most common subtype (2). In particular, soft-tissue sarco-
mas are uncommon, representing less than 1% of cancers 
(3). B-mode US may be used in more supericial lesions, 
given its low cost, ease of access, and high spatial resolution 
(4), with MRI usually performed to provide more deini-
tive characterization and local staging.
Traditionally, a combination of patient demographic 
information, especially age, and imaging features are used 
to attempt to characterize lesions on the benign-malignant 
spectrum. Features such as large lesion size and greater 
depth, irregular margin, heterogeneity, and invasion of lo-
cal structures, along with absence of deinitely benign fea-
tures (eg, purely cystic), are regarded as concerning (1,5,6).
Shear-wave elastography (SWE) is an emerging tech-
nique that uses US to provide quantitative data regard-
ing the biomechanical properties of tissue. By measuring 
the velocity of propagation of shear waves produced by 
the transducer, the elasticity of tissues can be inferred (7). 
SWE has been used to aid lesion characterization in a vari-
ety of body sites, most commonly in the breast (8) and liver 
(9), but also in the prostate (10) and thyroid (11). Within 
the ield of musculoskeletal imaging, SWE has mainly 
been used in evaluation of tendon disorders but has not 
yet found widespread clinical use (7). A small number of 
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Purpose: To examine if shear-wave elastography (SWE) improves the accuracy of diagnosing soft-tissue masses as benign or malig-
nant compared with US alone or in combination with MRI.
Materials and Methods: Two hundred six consecutive adult participants (mean age, 57.7 years; range, 18–91 years), including 89 
men (median age, 56.0 years; range, 21–91 years) and 117 women (median age, 59.1 years; range, 18–88 years), who were referred 
for biopsy of a soft-tissue mass were prospectively recruited from December 2015 through March 2017. Participants underwent 
B-mode US, MRI, and SWE prior to biopsy. hree musculoskeletal radiologists independently reviewed US images alone, followed 
by US and MRI images together, and classiied lesions as benign, probably benign, probably malignant, or malignant. For SWE, 
the area under the receiver operating characteristic (ROC) curve (AUC) was calculated for transverse shear-wave velocity (SWV). 
Multivariable logistic regression was used to investigate the association between SWE and malignancy alongside individual demo-
graphic and imaging variables.
Results: At histologic examination, 79 of 206 (38%) participants had malignant lesions. SWV showed good diagnostic accuracy 
for lesions classiied as benign or probably benign by US alone (AUC = 0.87 [95% conidence interval {CI}: 0.79, 0.95]). SWV did 
not provide substantive diagnostic information for lesions classiied as probably malignant or malignant, whether the classiication 
was made with or without MRI. However, multivariable modeling indicated that diagnostic accuracy may vary by lesion position 
(interaction P = .02; supericial, odds ratio [OR] = 17.7 [95% CI: 1.50, 207], P = .02; deep/mixed, OR = 0.24 [95% CI: 0.07, 
0.86], P = .03) and participant age (interaction P = .01; eg, age 43 years, OR = 0.72 [95% CI: 0.15, 3.5], P = .69; age 72 years, OR 
= 0.08 [95% CI: 0.02, 0.37], P = .001).
Conclusion: Shear-wave elastography can increase accuracy of soft-tissue lesion diagnosis in conjunction with US. However, a single 
cut-of may not be universally applicable with diagnostic accuracy that is afected by lesion position and patient age.
© RSNA, 2018
Online supplemental material is available for this article.
This copy is for personal use only. To order printed copies, contact reprints@rsna.org
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An initial assessment of US images alone was made while ra-
diologists were blinded to any prior MRI study indings and the 
shear-wave velocity (SWV) but were aware that all participants 
had undergone biopsy.
MRI Examination
A second assessment was independently performed based on 
a combination of anonymized US and MR images at least 3 
weeks after the scoring with US alone. MRI examinations for 
189 participants prior to biopsy were performed by using a 
1.5-T system (Magnetom Avanto; Siemens Healthcare, Erlan-
gen, Germany). T1-weighted and fat-suppressed T2-weighted 
images were obtained in two planes without intravenous con-
trast medium. he same assessment criteria were used (4) and 
readers were blinded to SWV.
For assessments based on US alone and US combined with 
MRI, analyses used the majority score (see statistical evaluation 
below) of the three independently obtained scores without dis-
cussion or further analysis by the radiologists.
US SWE
Before biopsy, two-dimensional SWE was performed by using 
a 9–4-MHz linear transducer (LOGIQ-E9; General Electric 
Health Care). his system has demonstrated substantial reli-
ability in comparison to other SWE systems (15). he system 
reports SWE readings in SWV (meters/second) and Young 
modulus (kilopascals). Both units are proportional to elasticity 
and can be used as a surrogate for tissue stifness.
Participants were placed in relaxed positions to ensure that 
no active (contraction) or passive (stretching) efects directly in-
luenced the elasticity results. An SWE rectangular elasticity box 
was ixed at a size of 1.5 cm 3 2 cm and a circular region of 
interest was used to cover and calculate elasticity within the most 
homogeneously solid and vascularized area (Fig 1a, 1b). Selected 
SWE maps were free from random inconsistent artifactual color 
patterns. Five repeated measurements in both craniocaudal and 
transverse planes were acquired by a board-qualiied musculo-
skeletal radiologist (P.R., with . 19 years of experience, includ-
ing . 3 years with SWE). In 100 participants, repeated SWE 
readings were independently acquired immediately after the irst 
scan by a board-qualiied sonographer (A.M.A., with 5 years of 
experience, including . 2 years with SWE) who was blinded to 
the irst scan measurements and clinical information. Total scan-
ning time ranged 5–10 minutes per reader.
Statistical Analysis
Sample size required for a multivariable logistic regression 
model of malignancy was based on an estimated malignancy 
rate of 37% from a previous study at this center (13). With 
13 independent variables, a minimum of 175 participants (65 
with malignant lesions) were required to provide at least ive 
events per variable, recommended in rules of thumb for logistic 
regression (16).
Multirater kappa (Ƹ) and category-speciic proportions of 
positive agreement were used to assess interradiologist agree-
ment over lesion classiication. Nonparametric areas under 
the receiver operating characteristic (ROC) curve (AUCs) 
Abbreviations
AUC = area under the ROC curve, CI = conidence interval, 
ICC = intraclass correlation coeicient, OR = odds ratio, ROC = 
receiver operating characteristic, SWE = shear-wave elastography, SWV = 
shear-wave velocity
Summary
Shear-wave elastography helps characterize musculoskeletal soft-tissue 
lesions as benign or malignant over evaluation with conventional US, 
but not when US is combined with MRI.
Implications for Patient Care
 n Shear-wave elastography can be used to add conidence to diag-
nosis of soft-tissue masses that appear benign or probably benign 
using conventional B-mode US.
 n Shear-wave elastography does not improve the diagnostic performance 
for such lesions when MRI is combined with conventional US.
 n he association between shear-wave velocity and malignancy may 
vary by lesion position and patient age.
studies have attempted to investigate the value of SWE in mus-
culoskeletal masses (12–14); the largest of these studies found no 
additional beneit of SWE over conventional US-based classii-
cation (13). We hypothesized that malignant soft-tissue masses 
have altered elasticity that is signiicantly diferent from that of 
benign masses, which can be detected using SWE.
he aim of this study was to examine whether SWE evalua-
tion, in addition to imaging-based assessor grading of conven-
tional US images alone and in combination with MR images, 
helps characterize soft-tissue masses as benign or malignant.
Materials and Methods
Patient Population
he study was approved by the institutional ethics review 
board, and written informed consent was obtained from all 
participants. he study prospectively screened 220 consecu-
tive patients suspected of having soft-tissue sarcoma who were 
referred for US-guided biopsy between December 2015 and 
March 2017 by a specialist sarcoma center. here were no ex-
clusion criteria. Histologic evaluation using the biopsy result 
or surgical specimen (where available) was used as the refer-
ence standard, with the pathologic diagnosis conirmed after 
analysis by one of two specialist soft-tissue sarcoma patholo-
gists. US and biopsy were performed by one of two musculo-
skeletal radiologists (H.G. and P.R., with 10 and 19 years of 
experience, respectively) using a 6–15-MHz linear transducer 
(LOGIQ-E9; General Electric Health Care, Milwaukee, Wis). 
All biopsies were performed percutaneously by using a mini-
mum 16-gauge core needle to obtain at least three cores.
B-Mode US
he anonymized US and MR images were reviewed indepen-
dently by three musculoskeletal radiologists (M.A., H.G., and P.R., 
with 3, 10, and 19 years of experience, respectively) who performed 
a visual assessment to categorize the lesions into one of four cat-
egories: benign, probably benign, probably malignant, or malig-
nant based on qualitative assessment using published criteria (4).
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the Youden index (sensitivity + speci-
icity 2 1; the probability of making 
an informed decision rather than a 
random guess). Penalized, or LASSO, 
binary logistic regression was used to 
determine the association with histo-
logically conirmed malignancy for 
individual US indings and SWVs, 
adjusted for demographic variables, 
choosing optimal lambda from a grid 
of starting values. Interactions be-
tween SWV and other variables were 
retained in the model if signiicant at 
P less than .1. All analyses were con-
ducted in Stata 14.1 (Stata, College 
Station, Tex).
Results
Of the 220 patients screened, 12 who 
did not or could not consent were 
not included in the study. Of the 208 
patients who had lesions assessed, 
two were excluded from analysis: 
one had an error in all SWE mea-
surements and the other was lost to 
follow-up, meaning that malignancy 
status could not be determined. All 
206 participants underwent US and 
SWE, and 189 of 206 participants 
underwent MRI prior to biopsy (see 
Fig 2 for participant lowchart). he 
mean age of the 206 participants was 
57.7 years (range, 18–91 years); for 
the 89 male participants, it was 56.0 
years (range, 21–91 years), and for 
the 117 female participants, it was 
59.1 years (range, 18–88 years). Pa-
thology was considered the reference 
standard (diagnoses listed in Table 
E1 [online] and clinical and imaging 
characteristics presented in Table E2 
[online]). Lipomas and liposarcomas were the most common 
benign and malignant lesions, respectively. Seventeen partici-
pants, ive with benign lesions and 12 with malignant lesions, 
did not have an MRI performed for clinical reasons, such as a 
small or supericial mass or claustrophobia.
MRI and US Reader Agreement for Lesion 
Classification
Agreement of MRI and US for lesion classiication was assessed 
in 189 participants with MR images available. By using US 
features alone to classify lesions, proportions of positive agree-
ment (ie, the probability that a lesion classiied into a category 
by one reader would be classiied into the same category by 
another) were 41%, 80%, 67%, and 64% for benign, probably 
benign, probably malignant, and malignant categories, respec-
tively (69% overall; multirater Ƹ, 0.55 [95% conidence inter-
were compared for classiications based on US alone versus US 
and MRI by using the Stata (Stata, College Station, Tex) roc-
comp command. Bland-Altman plots were used to compare 
SWE measurements by two diferent readers for 100 of the 
participants. Two-way mixed intraclass correlation coeicients 
(ICCs) were calculated for SWE measurements to evaluate the 
interobserver agreement. Lesion position was coded as deep 
intermuscular, deep intramuscular, subcutaneous, or mixed 
(deep intraintermuscular or deep subcutaneous).
he majority classiication categories from the three readers’ 
independently obtained scores for assessment of malignancy by 
US alone and by US and MRI combined were merged into the 
two categories, benign or probably benign and malignant or 
probably malignant, and the AUC was calculated for SWE within 
each merged category. We identiied the point yielding 100% 
sensitivity (false-negative rate, 0) and the point that maximized 
Figure 1: Shear-wave velocity (SWV) maps in (a) 46-year-old male participant with histologic 
diagnosis of lipoma and (b) 75-year-old female participant with histologic diagnosis of grade 3 
spindle cell sarcoma. The SWV color bar is set at a scale from 0 to 10 m/sec.
Table 1: Bland-Altman Limits of Agreement and Intraclass Correlation  
&RHIÀFLHQWVIRU6KHDU:DYH0HDVXUHPHQWV0DGHE\7ZR5HDGHUV
Shear-Wave Measurement
Geometric Mean
Bias 6 LOA ICC
(2, 1)
*Reader 1 Reader 2
Craniocaudal velocity (m/sec) 2.10 2.04 0.06 6 0.80 0.90 (0.85, 0.93)
Craniocaudal stifness (kPa) 15.70 14.91 1.45 6 15.60 0.89 (0.84, 0.92)
Transverse velocity (m/sec) 2.10 2.11 0.01 6 0.80 0.93 (0.89, 0.95)
Transverse stifness (kPa) 15.65 15.70 1.13 6 16.22 0.92 (0.88, 0.94)
Note.—ICC = intraclass correlation coeicient, LOA = limits of agreement.
* Data in parentheses are 95% conidence interval.
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value was 100% (63 of 63 [95% CI: 94%, 100%]); 66% of 
all lesions were correctly classiied. At velocity of 1.78 m/sec 
or less, where the Youden index was maximized, the sensitivity 
was 93% (13 of 14 [95% CI: 69%, 99%]), speciicity was 72% 
Figure 3: Bland-Altman plots of shear-wave velocity (SWV ) measurements by two 
readers in the (a) craniocaudal and (b) transverse planes. CI = confidence interval.
Figure 2: Flowchart of participants in the study. SWE = shear-wave 
elastography.
val {CI}: 0.48, 0.62]). By using US and MRI features com-
bined to classify lesions, the proportions of positive agreement 
were 25%, 87%, 74%, and 78%, respectively (77% overall; Ƹ, 
0.67 [95% CI: 0.61, 0.73]). When readers used both US and 
MRI features to classify lesions, the agreement between read-
ers improved (bootstrapped diference in Ƹ, 0.12 [95% CI: 
0.03, 0.20]; P = .01).
Agreement over SWE Measurements
Intraclass correlations for all four measures (SWV and stif-
ness measured in craniocaudal and transverse planes) were very 
high, with negligible mean diferences (Table 1). However, 
Bland-Altman limits of agreement were wide compared with 
the average measurement (Table 1, Fig 3). For SWV, 95% of 
repeat measurements were expected to lie within 20.74 and 
+0.86 m/sec of each other, when the mean measurement was 
approximately 2 m/sec. In concurrence with recent indings in 
a study of reliability of muscle SWE (15), overall agreement 
was better for SWV than for stifness (kPa). Due 
to high correlation (r = 0.82) between the two 
planes, only the most reliable measurements (trans-
verse SWV) were used in further analysis.
Does SWV Add Information Beyond 
Lesion Assessment with US Alone and US 
with MRI?
Majority classiication by the three radiologists 
showed diagnostic accuracy (AUC) of 0.82 (95% 
CI: 0.75, 0.89) when based on US alone, and this 
improved to 0.94 (95% CI: 0.90, 0.97) when 
based on US combined with MRI (x2
(1)
 = 11.7; 
P , .001). Sensitivity and speciicity, using each 
classiication category in turn as the cut-point for 
malignancy, are provided in Table 2. If we were to 
consider it safe to discharge patients with lesions 
graded benign by US alone, as is current practice, 
this would give a negative predictive value of 76%, 
indicating that some malignant lesions may be 
missed during US-only irst-line screening, reveal-
ing a potential role for SWE.
SWV grouped by imaging classiication cate-
gory and conirmed histologic status are presented 
in Figure E1 (online). he use of SWV alone for 
all lesions, with lower values assumed to indicate 
malignancy, did not demonstrate diagnostic accu-
racy better than chance (AUC = 0.53 [95% CI: 
0.44, 0.61]). However, of the 116 lesions classi-
ied as benign or probably benign by US alone, 
14 were malignant at histologic examination. For 
this group, the AUC was 0.87 (95% CI: 0.79, 
0.95) (Fig E1a [online]; Fig 4a). In lesions clas-
siied as benign or probably benign by US alone, 
at transverse SWV of 2.02 m/sec or less, sensitiv-
ity was 100% (14 of 14 [95% CI: 78%, 100%]), 
speciicity was 62% (63 of 102 [95% CI: 52%, 
71%]), positive predictive value was 26% (14 of 
53 [95% CI: 16%, 40%]), and negative predictive 
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as benign was malignant, 
limiting the additional 
beneit SWE could ofer. 
Among lesions classiied 
as probably malignant 
or malignant by US and 
MRI combined (n = 92; 
66 malignant), there was 
no evidence that SWV 
ofered additional diag-
nostic information (AUC 
= 0.58 [95% CI: 0.46, 
0.71]) (Fig E1c [online]). 
his remained the case 
when restricted to lipo-
matous lesions (n = 28; 
eight malignant; AUC 
= 0.64 [95% CI: 0.43, 
0.86]) (Fig E1d [online]).
Does Association 
between SWV 
and Malignancy Differ according to Individual 
Demographic and US Variables?
Odds of malignancy associated with demographic, US, and 
SWE variables are presented in Table 3. Statistically signiicant 
interactions were identiied between SWV and both age (P = 
.01) and lesion position (overall P = .02). LASSO removed the 
interaction for deep and mixed-position lesions, but a large 
interaction efect remained for subcutaneous lesions. SWVs 
observed in diferent positions are presented in Figure E3 (on-
line). Estimates from the inal multivariable model in Table 
3 showed that subcutaneous lesions with higher SWVs were 
more likely to be malignant (odds ratio [OR] = 17.66 [95% 
CI: 1.50, 207.47]; P = .02) (Fig 5a). However, for lesions that 
were deep intermuscular, deep intramuscular, or in a mix of 
positions, the direction of association was reversed (OR = 0.24 
(73 of 102 [95% CI: 62%, 79%], positive predictive value was 
31% (13 of 42 [95% CI: 19%, 46%]), and negative predictive 
value was 99% (73 of 74 [95% CI: 93%, 100%]). Restricting 
the lipomatous lesions (n = 49; 13 malignant) to the largest 
subgroup of masses, SWV still showed evidence of diagnostic 
ability (AUC = 0.74 [95% CI: 0.59, 0.89]) (Fig E1b [online]; 
Fig 4b). he ROC curve for the inal model prediction is pre-
sented in Figure E2 (online).
For lesions classiied as probably malignant or malignant by 
US alone (n = 90; 65 malignant), SWV alone did not demon-
strate any diagnostic beneit (AUC = 0.50 [95% CI: 0.37, 0.63]) 
(Fig E1a [online]). None of the lipomatous lesions in this sub-
group were found to be benign (Fig E1b [online]).
Using classiication by US and MRI combined, none of the 
lesions classiied as probably benign and only one lesion classiied 
7DEOH&ODVVLÀFDWLRQ6XFFHVVIRU0DMRULW\&ODVVLÀFDWLRQRI7KUHH5HDGHUV&ODVVLI\LQJ/HVLRQVZLWK86$ORQHRU86DQG
05,&RPELQHGLQ3DUWLFLSDQWVZLWK%RWK86DQG05,$YDLODEOH
Majority Classiication Benign (n = 122)* Malignant (n = 67)* Sensitivity (%)† Speciicity (%)†
Positive Predictive  
Value (%)†
Negative Predictive 
Value (%)†
US alone
 Benign 13 (11) 4 (6) 100 (95, 100) 0 (0, 3) 35 (29, 42) Not applicable
 Probably benign 85 (70) 9 (13) 94 (86, 98) 11 (6, 17) 37 (30, 44) 76 (53, 90)
 Probably malignant 21 (17) 26 (39) 81 (70, 88) 80 (72, 86) 69 (58, 78) 88 (81, 93)
 Malignant 3 (2) 28 (42) 42 (31, 54) 98 (93, 99) 90 (75, 97) 75 (68, 81)
US and MRI combined
 Benign 7 (6) 1 (1) 100 (95, 100) 0 (0, 3) 35 (29, 42) Not applicable
 Probably benign 89 (73) 0 (0) 99 (92, 100) 6 (3, 11) 36 (30, 44) 88 (53, 98)
 Probably malignant 23 (19) 24 (36) 99 (92, 100) 79 (71, 85) 72 (62, 80) 99 (94, 100)
 Malignant 3 (2) 42 (63) 63 (51, 73) 98 (93, 99) 93 (82, 98) 83 (76, 88)
* Data in parentheses are percentages.
† Data in parentheses are 95% conidence interval. Calculated using each category as the cut-of for malignancy, that is, using the benign 
category as the cut-of is equivalent to assuming all lesions are malignant.
Figure 4: Receiver operating characteristic (ROC) curve for transverse shear-wave velocity predicting malig-
nancy in lesions classified as benign or probably benign using US alone in (a) all lesions (area under the ROC 
curve [AUC] = 0.87 [95% confidence interval {CI}: 0.79, 0.95]) and (b) lipomatous lesions only (AUC = 0.74 
[95% CI: 0.59, 0.89]).
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,QGLYLGXDO%0RGH9DULDEOHVDQG6KHDU:DYH9HORFLW\
Independent Variable
Conirmed Lesion Status Odds Ratio
Benign*  
(n = 127)
Malignant*  
(n = 79)
Univariable† P Value Multivariable 
without SWV†
P Value Multivariable 
with SWV†
P Value
Mean age (y) at imaging 53.3 6 17.5 64.8 6 17.5 1.04 (1.02, 
1.06)
,.001 1.05 (1.02, 
1.08)
,.001 1.06 (1.03, 
1.09)
,.001
No. of female participants 61 (48) 26 (35) 0.59 (0.33, 
1.06)
.08 0.81 (0.37, 
1.78)
.60 0.61 (0.25, 
1.47)
.27
Lesion volume (cm3),  
  geometric mean
30.1 94.7 1.44 (1.21, 
1.71)
,.001 1.55 (1.21, 
2.00)
.001 1.66 (1.24, 
2.21)
.001
Heterogeneity present 87 (69) 58 (73) 1.27 (0.68, 
2.37)
.45 0.52 (0.18, 
1.53)
.24 0.59 (0.17, 
2.02)
.40
Necrosis present 22 (17) 32 (41) 3.25 (1.71, 
6.18)
,.001 2.74 (1.10, 
6.82)
.03 3.43 (1.24, 
9.43)
.02
Echotexture
 Hyper 22 (17) 6 (8) Reference Reference Reference
 Mixed 50 (39) 25 (32) 1.83 (0.65, 
5.10)
.24 0.88 (0.21, 
3.69)
.86 0.89 (0.16, 
4.91)
.89
 Hypo 55 (43) 48 (61) 3.20 (1.20, 
8.55)
.02 2.73 (0.69, 
10.80)
.15 5.44 (1.01, 
29.23)
.05
Doppler
 Absent 70 (55) 17 (22) Reference Reference Reference
 Linear 27 (21) 6 (8) 0.92 (0.33, 
2.57)
.87 1.00 (0.99, 
1.01)
..99 1.00 (0.99, 
1.01)
..99
 Disorganized 30 (24) 56 (71) 7.69 (3.85, 
15.34)
,.001 11.59 (4.60, 
29.16)
.001 16.53 (5.74, 
47.64)
,.001
Position
 Deep intermuscular 37 (29) 14 (18) Reference Reference Reference
 Deep intramuscular 53 (42) 32 (41) 1.60 (0.75, 
3.40)
.22 1.00 (0.99, 
1.01)
..99 1.35 (0.47, 
3.88)
.57
 Subcutaneous 36 (28) 22 (28) 1.62 (0.72, 
3.64)
.24 1.04 (0.43, 
2.55)
.93 1.05 (0.29, 
3.87)
.94
 Mixed 1 (,1) 11 (14) 29.07 (3.43, 
246.47)
.002 2.74 (0.38, 
19.51)
.31 6.14 (0.65, 
57.63)
.11
SWV (m/sec), geometric 
mean
2.31 2.23 0.82 (0.42, 
1.57)
.54 … … 0.24 (0.07, 
0.86)
.03
SWV 3 age … … … … … … 0.93 (0.87, 
0.98)
.01
SWV 3
 Deep intramuscular … … … … … … 1.00 (0.98, 
1.02)
..99
 Subcutaneous … … … … … … 74.68 (5.17, 
1078.62)
.002
 Mixed … … … … … … 1.00 (0.95, 
1.05)
..99
Note.—SWV = shear-wave velocity in the transverse plane.
* Data for mean age are mean 6 standard deviation. Data in parentheses are percentages.
† Data in parentheses are 95% conidence interval.
[95% CI: 0.07, 0.86]; P = .03) (Fig 5b, 5c). Age also modiied 
the association between SWV and malignancy; for example, 
in deep lesions there was no association in younger partici-
pants (estimated at age 43 years, OR = 0.72 [95% CI: 0.15, 
3.55], P = .69) but the association increased in strength with 
age (at age 59 years, OR = 0.21 [95% CI: 0.06, 0.78], P = 
.02; at age 72 years , OR = 0.08 [95% CI: 0.02, 0.37], P = 
.001) (Fig 5b). For participants with lesions that spread across 
multiple locations, the pattern with respect to age and SWV 
was the same as for deep lesions, although the risk of malig-
nancy was higher (Fig 5c).
Discussion
Our results show that while SWV alone was not diagnostic of ma-
lignancy, it improved the diagnostic ability of imaging-based clas-
siication using US alone when lesions were initially believed 
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al found that malignant soft-tissue lesions were harder com-
pared with subcutaneous epidermoid cysts (28). he strain 
elastography method used in the previous studies is based 
on a qualitative mechanical compression technique, which is 
therefore prone to operator-induced variability.
Limitations of this study include the lack of statistical test-
ing for all malignant subtypes. he umbrella term soft-tissue 
sarcoma encompasses a large range of rare mesenchymal lesions 
whose constitution may vary greatly; such wide variation does 
not occur in the other tumor groups evaluated by SWE to date, 
namely breast and thyroid. However, a small number of malig-
nant soft-tissue lesions tend to predominate (29) and those en-
countered tend to have fairly consistent overall imaging appear-
ances, namely lobulated mass lesions, which are hypoechoic on 
US and have high signal intensity on T2-weighted MR images 
(5). Nonetheless, this relects clinical decision making, which in 
the initial workup usually approaches soft-tissue lesions in a bi-
nary benign-versus-malignant framework. Our study population 
to be benign or probably benign. No additional 
beneit of SWE was seen when assessment based 
on US alone was indicative of a possible or dei-
nite malignancy. In clinical practice when a lesion 
is considered potentially malignant, further evalu-
ation (MRI and/or biopsy) is usually considered 
mandatory. Hybrid techniques combining visual 
inspection and quantitative methods such as SWE 
may provide additional conidence that a lesion 
is benign, and more invasive measures such as bi-
opsy can be avoided as has been reported in breast 
radiology (8,17–19). SWE could be useful in 
avoiding unnecessary interventions, medical costs, 
and distress for patients.
A critical factor for an imaging biomarker, espe-
cially a quantitative one, is its reproducibility. We 
found near-perfect interreader reliability (. 0.89), 
similar to indings of other investigators (20–22). 
Despite this, the limits of agreement were wide; for 
velocity, 95% of measurements were expected to lie 
within 20.74 and +0.86 m/sec of each other, when 
the mean measurement was approximately 2 m/sec. 
his could be potentially improved by acquiring 
additional SWE measurements per lesion.
Our results do not support an additional 
beneit of SWE when used in conjunction with 
both US and MRI. his is in contrast to studies 
in breast lesions where SWE and MRI combined 
outperformed MRI alone (23). It seems that 
SWE is potentially another variable that cannot 
be speciic for malignancy in soft-tissue tumors. 
As shown in Table 3, age, increasing lesion size, 
lesion necrosis, and disorganized lesion Doppler 
low were signiicantly linked to malignant le-
sions, but these features can all still be associated 
with benign soft-tissue pathology.
As with previous reports, our data suggest that 
slower SWVs are found in deeply located ma-
lignant soft-tissue lesions (12,13). Shear waves 
propagate faster in stifer tissues (24); therefore, lower SWVs 
indicate malignant soft-tissue lesions are softer or less stif. 
his is contrary to what has been reported in other organs, 
such as the breast, prostate, and thyroid, where greater tis-
sue stifness (and therefore higher SWV) is associated with 
greater likelihood of malignancy (9,11). Nevertheless, thy-
roid follicular cell carcinomas can be soft (25) due to greater 
cellularity and lower ibrous content (26). In contrast to our 
results in deeply located lesions, higher SWVs in subcuta-
neous lesions were associated with malignancy. he inverted 
relationship between supericial and deep lesions may relate 
to difering bioelastic properties of the lesion subtypes that 
tend to predominate in either compartment (27) or difering 
properties of the surrounding tissues, being subcutaneous fat 
and striated muscle, respectively, which may also be afected 
by aging. Magarelli et al used strain elastography to evaluate 
soft-tissue lesions and found that malignant lesions tended to 
be stifer, but only evaluated 32 lesions (14). Similarly, Park et 
Figure 5: Estimated probabilities of malignancy for different combinations of shear-
wave velocity (SWV), age, and lesion position. Estimates calculated for SWV at 5th, 
25th, 50th, 75th, and 95th percentiles and age at quartiles within each lesion position 
category, while holding all other covariates at the reference category (categorical co-
variates) or at the mean (continuous covariates). (a) Subcutaneous, (b) deep (intra- or 
intermuscular), and (c) mixed (subcutaneous and deep intra- and/or intermuscular).
Tavare et al
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is likely to have a bias toward malignant lesions, given that only 
those participants who had already been referred for biopsy were 
included. It should be noted that the numbers within subgroups 
did become very small when analysis was restricted to lipoma-
tous lesions, which might have afected the robustness of sta-
tistical secondary analysis. Although interreader reliability was 
measured and appeared excellent, no assessment of intrareader 
variation was performed. Both SWE operators had extensive ex-
perience in performing the technique and others’ results may not 
be as reproducible, although a substantial part of the modality is 
largely semiautomated.
In conclusion, although shear-wave elastography does not 
have independent predictive ability, its supplemental use is able 
to improve the classiication performance of assessment using 
US alone when compared with histologic evaluation. Given the 
ubiquity of lipomatous lesions and the di culties in managing 
them, further evaluation of the role of shear-wave elastography 
in lesion classiication should be performed, especially given that 
its most powerful ability appears to be adding credence to the 
impression of benignity based on US alone.
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